US 8344138
Triazinedione derivatives as GABAB receptor modulators
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8344138 (Triazinedione derivatives as GABAB receptor modulators) held by Addex Pharma, S.A. expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Addex Pharma, S.A.
- Grant date
- Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/14, A61P13/10